Skip to Main Content

Paper Details

Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.
Nat Commun
172
2019
ATRX, ATRX mutations, BRAF, CDK4, CDK4/6, CHD8, CTNNB1, HLA-A, KIT, MDM2, MEK, NF1, NRAS, SF3B1, SPRED1, TERT, TP53, Tumors, WNT, driver gene, genital and anorectal melanomas, mucosal melanoma, mucosal melanomas, telomere, tumor, tumors
Author NameAffiliation
Ann-Marie PatchQIMR Berghofer Medical Research Institute
Ann-Marie PatchQIMR Berghofer Medical Research Institute
Katia NonesQIMR Berghofer Medical Research Institute
Katia NonesQIMR Berghofer Medical Research Institute
Reinhard DummerDermatology Clinic, University Hospital Zurich, University of Zurich
Reinhard DummerDermatology Clinic, University Hospital Zurich, University of Zurich
Mitchell P LevesqueDermatology Clinic, University Hospital Zurich, University of Zurich
Mitchell P LevesqueDermatology Clinic, University Hospital Zurich, University of Zurich
Georgina V LongMelanoma Institute Australia, The University of Sydney
Georgina V LongRoyal North Shore and Mater Hospitals
Georgina V LongSydney Medical School, The University of Sydney
David J AdamsWellcome Trust Sanger Institute
John V PearsonQIMR Berghofer Medical Research Institute
John V PearsonQIMR Berghofer Medical Research Institute
Nicholas K HaywardQIMR Berghofer Medical Research Institute
Nicholas K HaywardQIMR Berghofer Medical Research Institute
Nicola WaddellQIMR Berghofer Medical Research Institute
Nicola WaddellQIMR Berghofer Medical Research Institute
Richard A ScolyerMelanoma Institute Australia, The University of Sydney
Richard A ScolyerSydney Medical School, The University of Sydney
Richard A ScolyerRoyal Prince Alfred Hospital
  • 1 - 21

Datasets